View Older Stories View More Recent Stories

May 14, 2015 08:00AM OncoCyte Corporation Completes Equity Financing Round
May 13, 2015 08:00AM BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.6 Million Grant From Israel’s Office of the Chief Scientist
May 11, 2015 08:00AM BioTime, Inc. Reports First Quarter 2015 Results and Recent Corporate Accomplishments
May 4, 2015 08:00AM Cell Cure Neurosciences Announces Preclinical Efficacy Data Demonstrating OpRegen® Preserves Vision
Apr 27, 2015 09:00AM BioTime’s Clinical Grade Stem Cells From Subsidiary ES Cell International to Be Used in Planned CIRM-Funded Preclinical Studies of Huntington’s Disease
Apr 22, 2015 08:00AM BioTime Licenses Beckman Research Institute of City of Hope to Manufacture Clinical Grade Stem Cells
Apr 20, 2015 12:00PM OncoCyte Announces Initial Data From Ongoing Clinical Study of Collagen Type X as a Marker and Potential Diagnostic for Breast Cancer and Other Types of Human Cancers
Apr 20, 2015 06:30AM Positive Clinical Results of OncoCyte’s PanC-Dx™ Diagnostic Test Demonstrate High Level of Sensitivity and Specificity in Non-Invasive Detection of Bladder Cancer
Mar 31, 2015 09:00AM LifeMap Solutions and Mount Sinai – National Jewish Health Respiratory Institute Launch Pilot Program of COPD Navigator App
Mar 20, 2015 08:00AM OncoCyte Announces Availability of Abstracts With New Clinical Data From Studies of PanC-Dx™ Cancer Diagnostic in Bladder and Breast Cancer
Mar 11, 2015 08:00AM BioTime, Inc. Reports Fourth Quarter and Fiscal Year End 2014 Financial Results and Recent Corporate Accomplishments
Mar 9, 2015 02:48PM Icahn School of Medicine at Mount Sinai and LifeMap Solutions Launch Asthma Study for iPhone
View More Recent Stories View Older Stories